Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens

Mismatch repair (MMR) testing on all new cases of colorectal cancer (CRC) has customarily been preferably performed on surgical specimens, as more tissue is available; however, new clinical trials for the use of immune checkpoint inhibitors in the neoadjuvant setting require MMR testing on biopsy sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Grillo, F., Paudice, M., Gambella, A., Bozzano, S., Sciallero, S., Puccini, A., Lastraioli, S., Dono, M., Parente, P., Vanoli, A., Angerilli, V., Fassan, M., Mastracci, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386921/
https://www.ncbi.nlm.nih.gov/pubmed/37284845
http://dx.doi.org/10.1007/s00418-023-02202-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386921/
https://www.ncbi.nlm.nih.gov/pubmed/37284845
http://dx.doi.org/10.1007/s00418-023-02202-8

Ejemplares similares